FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, Jul 20, 2018
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on July 20, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · fbec913a-a6fb-4391-a4cc-6d977cd24933
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1059746
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.40(a)(1)Provide space for examination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 22, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 26, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 13, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc
- FDA Inspection 1233249 - 2024-02-22
- FDA Inspection 1028540 - 2017-07-26
- FDA Inspection 818852 - 2013-02-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.